Evidence map›Paper›PMID 33147609›Full record

ArticleRheumatology (Oxford, England)2021

Burden of illness among subgroups of patients with primary Sjögren's syndrome and systemic involvement.

Kerry Gairy, Claudia Knight, Papa Anthony, Ben Hoskin

Abstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Insights into Patient Heterogeneity in Sjögren's Disease.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. What can patients tell us in Sjögren's syndrome?Rheumatology and immunology research · 2024
    Review
  11. Article
  12. New developments in Sjogren's syndrome.Rheumatology (Oxford, England) · 2021
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kerry GairyValue Evidence & Outcomes, GlaxoSmithKline, Brentford, Middlesex, UK.
Claudia KnightAdelphi Real World, Adelphi Group, Macclesfield, Cheshire, UK.
Papa AnthonyAdelphi Real World, Adelphi Group, Macclesfield, Cheshire, UK.
Ben HoskinAdelphi Real World, Adelphi Group, Macclesfield, Cheshire, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo describe how patients with primary SS (pSS) and systemic organ involvement are classified and clustered in routine practice.

methodsThis multinational, cross-sectional survey of real-world quantitative data was conducted across Europe and the US. Rheumatologists who treated seven or more adult patients per month with pSS and current/past systemic manifestations undertook a survey before completing a patient record form capturing demographic, clinical and treatment information for their next six eligible patients. Patients with a completed patient record form were invited to complete a patient self-completion questionnaire capturing insights into their disease and treatment. Subgroups were defined by physicians' assessment of disease severity; clusters were derived based on key clinical characteristics using latent class analysis.

resultsRheumatologists completed 316 physician surveys and 1879 patient record forms; 888 patients completed the patient self-completion questionnaire. pSS severity reflected organ involvement and symptomatology. Latent class analysis produced five clusters distinguished by the organ systems involved and the presence of pain and fatigue symptoms at the time of the survey. A minority of patients [n = 67 (4%)] were categorized with multiple organ involvement and the highest frequency of pain and fatigue. A total of 324 patients (17%) were categorized as 'low burden'. The remaining three clusters exhibited high frequencies of articular involvement but were distinguished by the extent of other organ system involvement.

conclusionCluster analysis using a real-world cohort of patients with pSS and systemic organ involvement highlights the heterogeneous presentation of patients with pSS and confirms the importance of pain and fatigue as well as organ involvement when determining disease burden.

Indexed as

Cost of IllnessCluster AnalysisCross-Sectional StudiesFatigueFemaleHumansMaleMiddle AgedPainPatient SatisfactionSeverity of Illness IndexSjogren's SyndromeSurveys and Questionnairescluster analysislatent class analysisprimary Sjögren’s syndromereal-world evidencesystemic autoimmune disease

Identifiers

PMID33147609
PMCPMC8023993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.